Production of antigen-specific human monoclonal antibodies: Comparison of mice carrying IgH/κ or IgH/κ/λ transloci

BioTechniques

Volumn 33, Issue 3, 2002, Pages 680-690

  Magadan S ^a   Valladares, M ^a   Suarez, E ^a   Sanjuan I ^a   Molina, A ^a   Ayling, C ^a   Davies, S L ^a   Zou, X ^a   Williams, G T ^a   Neuberger, M S ^a   Bruggemann M ^a   Gambon F ^a   Diaz Espada F ^a   González Fernández, África ^a  

^a UNIVERSITY OF VIGO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BLOOD; CELLS; IMMUNOLOGY; PATIENT TREATMENT; TUMORS;

CELL LINES;

MONOCLONAL ANTIBODIES;

HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN IDIOTYPE; IMMUNOGLOBULIN M; IMMUNOGLOBULIN KAPPA CHAIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; GENE DISRUPTION; GENE LOCUS; HUMAN; HUMAN CELL; MOUSE; MOUSE STRAIN; NONHUMAN; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; HYBRIDOMA; IMMUNOLOGY; MONOCYTE; MOUSE MUTANT; PHYSIOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENCE; SPLEEN; TRANSGENIC MOUSE;

ANIMALIA;

ANIMALS; ANTIBODIES, MONOCLONAL; GENE EXPRESSION REGULATION; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN M; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MONOCYTES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; SPLEEN;

EID: 1842842564     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/02333dd04     Document Type: Article

References (32)

1. Aucouturier, P., M. Capella, S. Briault, F. Danon, L. Intrator, and J.L. Preud'homme. 1987. Caractérisation des immunoglobulines monoclonales dans les liquides biologiques par immunoempreinte sur nitrocellulose. Rev. Inst. Pasteur Lyon 20:147-153.
2. Barrios, Y., A. Plaza, R. Cabrera, R. Yañez, E. Suarez, M.N. Fernández, and F. Díaz-Espada. 2001. Active idiotypic vaccination in a patient with biclonal follicular lymphoma. Cancer Immunol. Immunother. 50:87-92.
3. Bjornson, A.B. and P.A. Detmers. 1995. The pentameric structure of IgM is necessary to enhance opsonization of Bacteroides thetaiotaomicron and Bacteroides fragilis via the alternative complement pathway. Microb. Pathog. 19:117-128.
4. Brüggemann, M., H.M. Caskey, C. Teale, H. Waldmann, G.T. Williams, M.A. Surani, and M.S. Neuberger. 1989. A repertoire of monoclonal antibodies with human heavy chains from transgenic mice. Proc. Natl. Acad. Sci. USA 86:6709-6713.
5. Brüggemann, M., C. Spicer, L. Buluwela, I.R. Rosewell, S. Barton, M.A. Surani, and T.H. Rabbitts. 1991. Human antibody production in transgenic mice: Expression of 100 kb of the human IgH locus. Eur. J. Immunol. 5:1323-1326.
6. 2 IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies. J. Neuroimmunol. 114:226-231.
7. Cattaneo, A. and M.S. Neuberger. 1987. Polymeric immunoglobulin M is secreted by transfectants of non-lymphoid cells in the absence of immunoglobulin J chain. EMBO J. 6:2753-2758.
8. Choi, T.K., P.W. Hollenbach, B.E. Pearson, R.M. Ueda, G.N. Weddell, C.G. Kurahara, C.S. Woodhouse, R.M. Kay, et al. 1993. Transgenic mice containing a human heavy chain immunoglobulin gene fragment cloned in a yeast artificial chromosome. Nat. Genet. 4:117-123.
9. Davis, C.G., M.L. Gallo, and J.R. Corvalan. 1999. Transgenic mice as a source of fully human antibodies for the treatment of cancer. Cancer Metastasis Rev. 18:421-425.
10. Dyer, M.J., G. Hale, F.G. Hayhoe, and H. Waldmann. 1989. Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: Influence of antibody isotype. Blood 73:1431-1439.
11. Edwards, P.A., C.M. Smith, A.M. Neville, and M.J. O'Hare. 1982. A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur. J. Immunol. 12:641-648.
12. Galfre, G. and C. Milstein. 1981. Preparation of monoclonal antibodies: Strategies and procedures. Methods Enzymol. 73:3-46.
13. Gherardi, E., R. Pannell, and C. Milstein. 1990. A single-step procedure for cloning and selection of antibody-secreting hybridomas. J. Immunol. Methods 126:61-68.
14. Gillis, S. and J. Watson. 1980. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J. Exp. Med. 152:1709-1719.
15. Golay, J., M. Lazzari, V. Facchinetti, S. Bernasconi, G. Borleri, T. Barbui, A. Rambaldi, and M. Introna. 2001. CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: Further regulation by CD55 and CD59. Blood 98:3383-3389.
16. Green, L.L. 1999. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies. J. Immunol. Methods 231:11-23.
17. Green, L.L., M.C. Hardy, C.E. Maynard-Currie, H. Tsuda, D.M. Louie, M.J. Mendez, H. Abderrahim, M. Noguchi, et al. 1994. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat. Genet. 7:13-21.
18. Huang, J., D. Gou, C. Zhen, D. Jiang, X. Mao, W. Li, S. Chen, and C. Cai. 2001. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59, and MCP. FEMS Immunol. Med. Microbiol. 31:203-209.
19. Hughey, C.T., J.W. Brewer, A.D. Colosia, W.F. Rosse, and R.B. Corley. 1998. Production of IgM hexamers by normal and autoimmune B cells: Implications for the physiologic role of hexameric IgM. J. Immunol. 161:4091-4097.
20. Kitamura, D., J. Roes, R. Kühn, and K. Rajewsky. 1992. Targeted disruption of μ chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 356:154-156.
21. Klein, E., G. Klein, J.S. Nadkarni, J.J. Nadkarni, H. Wigzell, and P. Clifford. 1968. Surface IgM-κ specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res. 28:1300-1310.
22. Köhler, G. and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
23. Lonberg, N., L.D. Taylor, F.A. Harding, M. Troustine, K.M. Higgings, S.R. Schramm, C.-C. Kuo, R. Mashayekh, et al. 1994. Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 368:856-859.
24. Ma, J., J.F. Kearney, and L.M. Hendershot. 1990. Association of transport-defective light chains with immunoglobulin heavy chain binding protein. Mol. Immunol. 27:623-630.
25. Macpherson, A.J., A. Lamarre, K. McCoy, G.R. Harriman, B. Odermatt, G. Dougan, H. Hengartner, and R.M. Zinkernagel. 2001. IgA production without μ or δ chain expression in developing B cells. Nat. Immunol. 2:625-631.
26. Nicholson, I.C., X. Zou, A.V. Popov, G.P. Cook, E.M. Corps, S. Humphries, C. Ayling, B. Goyenechea, et al. 1999. Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and κ and λ light chain yeast artificial chromosomes. J. Immunol. 163:6898-6906.
27. Popov, A.V., X. Zou, J. Xian, I.C. Nicholson, and M. Brüggemann. 1999. A human λ locus is similarly well expressed in mice and humans. J. Exp. Med. 189:1611-1620.
28. Sundstrom, C. and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17:565-577.
29. Terasaki, P.I.E.A. 1972. In J.G. Roy, Jr., P.D. Pedersen, D.E. Kayhoe, and D.B. Hare (Eds.), Manual of Tissue Typing Techniques. National Institutes of Health, Bethesda, MD.
30. Tomizuka, K., T. Shinohara, H. Yoshida, H. Uejima, A. Ohguma, S. Tanaka, K. Sato, M. Oshimura, et al. 2000. Double trans-chromosomic mice: Maintenance of two individual human chromosome fragments containing Ig heavy and κ loci and expression of fully human antibodies. Proc. Natl. Acad. Sci. USA 97:722-727.
31. Wagner, S.D., G.T. Williams, T. Larson, M.S. Neuberger, D. Kitamura, K. Rajewsky, J. Xian, and M. Brüggemann. 1994. Antibodies generated from human immunoglobulin miniloci in transgenic mice. Nucleic Acids Res. 8:1389-1393.
32. Zou, X., J. Xian, A.V. Popov, I.R. Rosewell, M. Muller, and M. Brüggemann. 1995. Subtle differences in antibody responses and hypermutation of λ light chains in mice with a disrupted κ constant region. Eur. J. Immunol. 25:2154-2162.